NOVONIX Limited (ASX: NVX) Announces CEO Transition
CEO Transition
NOVONIX Limited (ASX: NVX) has announced the transition of Dr. Chris Burns from the CEO role, effective 24 January 2025. Dr. Burns, who has led the company since September 2020, will continue his association as a Special Advisor to the Board of Directors. This change comes as NOVONIX prepares for commercial-scale production at its Riverside facility and strives for growth in its synthetic graphite production.
Interim Leadership
Mr. Robert Long, currently the Chief Financial Officer, has been appointed as the interim CEO. The Board will conduct a search for a permanent CEO with expertise in manufacturing and operations to guide NOVONIX’s growth strategy. Admiral Robert J. Natter, Chairman, expressed gratitude for Dr. Burns’ leadership and confidence in Mr. Long’s capabilities during this transition period. Dr. Burns noted, “I am incredibly proud of everything that NOVONIX has accomplished during my time as CEO.” He emphasized the importance of appointing a leader with the right skill set for the next growth phase.
Motley Fool contributor Abbie Stokes has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.